Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"With our team of experts, industry-leading biometric services, and proprietary technology, Bioforum empowers sponsors to seamlessly manage their clinical data in one place and ensure it's secure, accurate, and ready for analysis," said Amir Malka, CEO and co-founder of Bioforum. "We're excited to be strengthening our alliance with Medidata and, together, providing our customers with the adaptability and advanced solutions they need to thrive."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
LONDON -- Businesswire -- Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata&index=1&md5=1aed7352794475565478a4eeb7768a8f), a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that serves clinical trial sponsors worldwide.
Building on more than a decade of collaboration, the expanded partnership provides Bioforum’s biotech customers with broader access to Medidata’s AI-powered technology, enabling a more agile clinical development experience. In addition to Medidata solutions such as Medidata Rave EDC (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-trial-products%2Fclinical-data-management%2Fedc-systems%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata+Rave+EDC&index=2&md5=b0a7bc6101c23cceb3e86a0c97037847) and Medidata Rave RTSM (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-trial-products%2Fclinical-data-management%2Frtsm%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata+Rave+RTSM&index=3&md5=1de8cba4c1c363da911808713f403083), which Bioforum has leveraged to deliver 60 studies across a range of therapeutic areas, the CRO is adding Medidata Clinical Data Studio (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-data-studio%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata+Clinical+Data+Studio&index=4&md5=174dbc0e4ca3b15742d8c15c105b9697) and Medidata eConsent (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-trial-products%2Fpatient-centric-clinical-trials%2Feconsent%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata+eConsent&index=5&md5=b142e71c2976fa875f32d019604c59e6) to streamline data flow, maintain data integrity, and ensure compliance.
“With our team of experts, industry-leading biometric services, and proprietary technology, Bioforum empowers sponsors to seamlessly manage their clinical data in one place and ensure it’s secure, accurate, and ready for analysis,” said Amir Malka, CEO and co-founder of Bioforum. “We’re excited to be strengthening our alliance with Medidata and, together, providing our customers with the adaptability and advanced solutions they need to thrive.”
“Our expanded partnership with Bioforum brings AI-driven clinical trial management to agile biotech start-ups, accelerating their path to market,” said Janet Butler, executive vice president, head of global sales, Medidata. “By harnessing our Patient Data Surveillance and RBQM platforms, we’re delivering improved operational efficiency for Bioforum and seamless, high-quality data access for their clients.”
Bioforum will sponsor Medidata’s upcoming NEXT New York (https://bit.ly/4dXhIwV), a leading clinical trials conference hosted by the company, scheduled for November 13 to 14 in New York City.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all - consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.
About Bioforum the Data Masters
Bioforum the Data Masters is a leading global clinical research organization (CRO) that specializes in biometric services and solutions for the pharmaceutical, biotech and medical device industries. With a team of experienced professionals and state-of-the-art technology, Bioforum provides a range of services including data management, biostatistics, statistical programming and medical writing to help companies bring new drugs and therapies to market faster. To learn more about us and our services, visit www.bioforumgroup.com or find us on LinkedIn at https://il.linkedin.com/company/bioforum-ltd.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241112963841/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Medidata
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 헬리녹스, 창립 15주년 기념 100% 스케일 베어브릭 컬렉션 출시 - 뉴스와이어
- 서울시립청소년음악센터, 제1회 서울청소년댄스페스티벌 성료 - 뉴스와이어
- 애질리티 로보틱스, 모션 기술 기업 셰플러 그룹과 전략적 투자 및 합의 발표 - 뉴스와이어
- 대안공간 루프 ‘눈 홉뜨기: 디지털 파사드를 위한 제안들 Rolling Eyes: Proposals for Media Façade’ 개
- 베이진, 2024년 3분기 재무 결과 및 기업 업데이트 발표 - 뉴스와이어
- 콘진원, AI콘텐츠 페스티벌서 ‘뉴콘텐츠아카데미 프로젝트 전시’ 성황리에 마무리 - 뉴스와이
- LS일렉트릭-LS전선, 미래 초전도 혁신기술로 ‘CES 혁신상’ 영예 - 뉴스와이어
- 쿠팡과 함께하는 더 풍성해진 ‘유럽연합 푸드 위크’ - 뉴스와이어
- 현대차그룹, 2024년 대표이사·사장단 임원인사 - 뉴스와이어
- 라한호텔 포항, 울릉도 지역 수능 수험생 응원 - 뉴스와이어